155 related articles for article (PubMed ID: 12100458)
1. Parathyroid hormone metabolites in renal failure: bioactivity and clinical implications.
Brossard JH; Yamamoto LN; D'Amour P
Semin Dial; 2002; 15(3):196-201. PubMed ID: 12100458
[TBL] [Abstract][Full Text] [Related]
2. Evolution of the parathyroid hormone (PTH) assay--importance of circulating PTH immunoheterogeneity and of its regulation.
Gao P; D'Amour P
Clin Lab; 2005; 51(1-2):21-9. PubMed ID: 15719701
[TBL] [Abstract][Full Text] [Related]
3. Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH/PTH-related peptide receptor.
Nguyen-Yamamoto L; Rousseau L; Brossard JH; Lepage R; D'Amour P
Endocrinology; 2001 Apr; 142(4):1386-92. PubMed ID: 11250917
[TBL] [Abstract][Full Text] [Related]
4. Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor.
Divieti P; John MR; Jüppner H; Bringhurst FR
Endocrinology; 2002 Jan; 143(1):171-6. PubMed ID: 11751606
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of protein kinase C activity in cells expressing human parathyroid hormone receptors by C- and N-terminally truncated fragments of parathyroid hormone 1-34.
Whitfield JF; Isaacs RJ; Chakravarthy B; Maclean S; Morley P; Willick G; Divieti P; Bringhurst FR
J Bone Miner Res; 2001 Mar; 16(3):441-7. PubMed ID: 11277261
[TBL] [Abstract][Full Text] [Related]
6. Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism.
D'Amour P; Brossard JH; Rousseau L; Nguyen-Yamamoto L; Nassif E; Lazure C; Gauthier D; Lavigne JR; Zahradnik RJ
Kidney Int; 2005 Sep; 68(3):998-1007. PubMed ID: 16105030
[TBL] [Abstract][Full Text] [Related]
7. Amino-terminal modifications of human parathyroid hormone (PTH) selectively alter phospholipase C signaling via the type 1 PTH receptor: implications for design of signal-specific PTH ligands.
Takasu H; Gardella TJ; Luck MD; Potts JT; Bringhurst FR
Biochemistry; 1999 Oct; 38(41):13453-60. PubMed ID: 10521252
[TBL] [Abstract][Full Text] [Related]
8. Receptors for the carboxyl-terminal region of pth(1-84) are highly expressed in osteocytic cells.
Divieti P; Inomata N; Chapin K; Singh R; Jüppner H; Bringhurst FR
Endocrinology; 2001 Feb; 142(2):916-25. PubMed ID: 11159865
[TBL] [Abstract][Full Text] [Related]
9. PTHrP enhances the secretory response of PTH to a hypocalcemic stimulus in rat parathyroid glands.
Lewin E; Almaden Y; Rodriguez M; Olgaard K
Kidney Int; 2000 Jul; 58(1):71-81. PubMed ID: 10886551
[TBL] [Abstract][Full Text] [Related]
10. Origin of parathyroid hormone (PTH) fragments detected by intact-PTH assays.
Nguyen-Yamamoto L; Rousseau L; Brossard JH; Lepage R; Gao P; Cantor T; D'Amour P
Eur J Endocrinol; 2002 Jul; 147(1):123-31. PubMed ID: 12088929
[TBL] [Abstract][Full Text] [Related]
11. Binding and cyclic AMP stimulation by N-terminally deleted human PTHs (3-84 and 4-84) in a homologous ligand receptor system.
Olstad OK; Reppe S; Loseth OP; Jemtland R; Gautvik KM
J Bone Miner Res; 1997 Sep; 12(9):1348-57. PubMed ID: 9286750
[TBL] [Abstract][Full Text] [Related]
12. Inositol 1-,4-,5-trisphosphate-dependent Ca2+ signaling by the recombinant human PTH/PTHrP receptor stably expressed in a human kidney cell line.
Pines M; Fukayama S; Costas K; Meurer E; Goldsmith PK; Xu X; Muallem S; Behar V; Chorev M; Rosenblatt M; Tashjian AH; Suva LJ
Bone; 1996 Apr; 18(4):381-9. PubMed ID: 8726398
[TBL] [Abstract][Full Text] [Related]
13. Circulating PTH molecular forms: what we know and what we don't.
D'Amour P
Kidney Int Suppl; 2006 Jul; (102):S29-33. PubMed ID: 16810307
[TBL] [Abstract][Full Text] [Related]
14. Histidine at position 5 is the specificity "switch" between two parathyroid hormone receptor subtypes.
Behar V; Nakamoto C; Greenberg Z; Bisello A; Suva LJ; Rosenblatt M; Chorev M
Endocrinology; 1996 Oct; 137(10):4217-24. PubMed ID: 8828480
[TBL] [Abstract][Full Text] [Related]
15. Role of glycosylation in expression and function of the human parathyroid hormone/parathyroid hormone-related protein receptor.
Bisello A; Greenberg Z; Behar V; Rosenblatt M; Suva LJ; Chorev M
Biochemistry; 1996 Dec; 35(49):15890-5. PubMed ID: 8961954
[TBL] [Abstract][Full Text] [Related]
16. Acute and chronic regulation of circulating PTH: significance in health and in disease.
D'Amour P
Clin Biochem; 2012 Aug; 45(12):964-9. PubMed ID: 22569597
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of human parathyroid hormone 1-34 at 0.9-A resolution.
Jin L; Briggs SL; Chandrasekhar S; Chirgadze NY; Clawson DK; Schevitz RW; Smiley DL; Tashjian AH; Zhang F
J Biol Chem; 2000 Sep; 275(35):27238-44. PubMed ID: 10837469
[TBL] [Abstract][Full Text] [Related]
18. Evidence that the amino-terminal composition of non-(1-84) parathyroid hormone fragments starts before position 19.
D'Amour P; Brossard JH; Räkel A; Rousseau L; Albert C; Cantor T
Clin Chem; 2005 Jan; 51(1):169-76. PubMed ID: 15514090
[TBL] [Abstract][Full Text] [Related]
19. Type-1 parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptors activate phospholipase C in response to carboxyl-truncated analogs of PTH(1-34).
Takasu H; Bringhurst FR
Endocrinology; 1998 Oct; 139(10):4293-9. PubMed ID: 9751512
[TBL] [Abstract][Full Text] [Related]
20. Acute regulation of circulating parathyroid hormone (PTH) molecular forms by calcium: utility of PTH fragments/PTH(1-84) ratios derived from three generations of PTH assays.
D'Amour P; Räkel A; Brossard JH; Rousseau L; Albert C; Cantor T
J Clin Endocrinol Metab; 2006 Jan; 91(1):283-9. PubMed ID: 16219713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
